FFRct vs KardiaAI
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A (FFRct) is a diagnostic tool for coronary artery disease, utilizing AI to analyze CCTA scans and assess blood flow in 3D models of coronary arteries. In contrast, Tool B (KardiaAI) is an AI software library focused on analyzing ambulatory ECG rhythms to detect various cardiac arrhythmias. While both fall under cardiology AI, they address distinct cardiac conditions using different diagnostic modalities, making them complementary rather than directly competitive.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
HeartFlow FFRct Analysis is a non-invasive AI-powered diagnostic tool that creates personalized 3D models of coronary arteries from CCTA scans to assess blood flow and aid in diagnosing coronary artery disease (CAD). KardiaAI by AliveCor is an FDA-cleared AI software library for analyzing ambulatory ECG rhythms, detecting various cardiac conditions like AFib, bradycardia, and tachycardia.
HeartFlow FFRct Analysis processes data from CCTA (Coronary Computed Tomography Angiography) scans to generate personalized 3D digital models of coronary arteries and analyze blood flow. KardiaAI analyzes ambulatory ECG rhythms to detect various cardiac conditions.
The CMS payment rate for HeartFlow FFRct Analysis is $1,017 for 2025, with commercial payer rates varying. KardiaAI is subscription-based, with options such as KardiaCare Monthly at $13.99/month or KardiaCare Annual at $99.99/year.
HeartFlow FFRct Analysis is primarily designed for Cardiology and Radiology, focusing on the diagnosis and management of coronary artery disease. KardiaAI is relevant for Cardiology, Emergency Medicine, and Internal Medicine, focusing on heart rhythm analysis.
HeartFlow FFRct Analysis generates personalized 3D models of coronary arteries to analyze blood flow and identify areas of narrowing (FFRct values), aiding in CAD diagnosis and guiding treatment strategies. KardiaAI detects atrial fibrillation, bradycardia, tachycardia, normal sinus rhythm, Sinus Rhythm with Premature Ventricular Contractions (PVCs), Sinus Rhythm with Wide QRS, and Sinus Rhythm with Supraventricular Ectopy (SVE) from ECGs.
More Comparisons
Backers
Who funded each tool's parent company.